chr12-25216683-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_033360.4(KRAS):​c.451-1123T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.493 in 151,994 control chromosomes in the GnomAD database, including 19,385 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 19385 hom., cov: 32)

Consequence

KRAS
NM_033360.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.191

Publications

8 publications found
Variant links:
Genes affected
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
KRAS Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, PanelApp Australia
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Noonan syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • linear nevus sebaceous syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.779 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033360.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KRAS
NM_033360.4
MANE Plus Clinical
c.451-1123T>C
intron
N/ANP_203524.1
KRAS
NM_004985.5
MANE Select
c.451-6772T>C
intron
N/ANP_004976.2
KRAS
NM_001369786.1
c.451-1123T>C
intron
N/ANP_001356715.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KRAS
ENST00000256078.10
TSL:1 MANE Plus Clinical
c.451-1123T>C
intron
N/AENSP00000256078.5
KRAS
ENST00000311936.8
TSL:1 MANE Select
c.451-6772T>C
intron
N/AENSP00000308495.3
KRAS
ENST00000685328.1
c.451-6772T>C
intron
N/AENSP00000508921.1

Frequencies

GnomAD3 genomes
AF:
0.493
AC:
74832
AN:
151876
Hom.:
19373
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.328
Gnomad AMI
AF:
0.399
Gnomad AMR
AF:
0.501
Gnomad ASJ
AF:
0.624
Gnomad EAS
AF:
0.800
Gnomad SAS
AF:
0.668
Gnomad FIN
AF:
0.543
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.541
Gnomad OTH
AF:
0.506
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.493
AC:
74874
AN:
151994
Hom.:
19385
Cov.:
32
AF XY:
0.498
AC XY:
37002
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.328
AC:
13612
AN:
41462
American (AMR)
AF:
0.501
AC:
7653
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.624
AC:
2163
AN:
3468
East Asian (EAS)
AF:
0.800
AC:
4130
AN:
5164
South Asian (SAS)
AF:
0.667
AC:
3212
AN:
4814
European-Finnish (FIN)
AF:
0.543
AC:
5717
AN:
10536
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.541
AC:
36798
AN:
67956
Other (OTH)
AF:
0.507
AC:
1069
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1867
3734
5602
7469
9336
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
682
1364
2046
2728
3410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.509
Hom.:
2663
Bravo
AF:
0.482
Asia WGS
AF:
0.691
AC:
2402
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
9.1
DANN
Benign
0.83
PhyloP100
0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12822857; hg19: chr12-25369617; API